Shelton Wealth Management »

Halozyme Therapeutics shares owned by Shelton Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Shelton Wealth Management from 13F filings

Historical chart of Shelton Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Shelton Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Shelton Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $734k 18k 40.68

More positions owned by Shelton Wealth Management

First Tr Exchange-traded First Tr Enh New (FTSM)
Ishares Tr Rus Mid Cap Etf (IWR)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange Trad Fd Vi FST TR GLB FD (FTGC)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Msci Emrg Chn (EMXC)
First Tr Exch Traded Fd Iii Instl Pfd Secs (FPEI)
Spdr Ser Tr S&p Oilgas Exp (XOP)
Ishares Tr Expnd Tec Sc Etf (IGM)
Ishares Tr Ibonds 25 Trm Ts (IBTF)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Ibonds 29 Trm Ts (IBTJ)

View all positions for Shelton Wealth Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Jennifer Ranahan
Arrowpoint Asset Management
Northern Trust
Thrivent Financial for Lutherans
Bank of America Corporation
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics